Santos da Silva Jorge's Form 4 filing
MoonLake Immunotherapeutics (MLTX) · filed Dec 10, 2025
- Accession no.
- 0001213900-25-120106
- Filed
- Dec 10, 2025
- Trade date
- Dec 8-9, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.97M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Santos da Silva JorgeCIK 0001920509 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 | Class A ordinary shares, par value $0.0001 per share | SSaleDisposed | −130,000 | $15.08 | −$1,960,400 | 2,948,577 | Direct | |
| Dec 9, 2025 | Class A ordinary shares, par value $0.0001 per share | SSaleDisposed | −70,000 | $14.49 | −$1,014,300 | 2,878,577 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.